Latest Nature Biotechnology Stories
Weill Cornell Medical College study lays groundwork for new treatments for cardiovascular disease and other conditions.
Publication in Nature Biotechnology validates company's structure-based approach for addressing previously undruggable targets.
Global climate change has prompted efforts to drastically reduce emissions of carbon dioxide, a greenhouse gas produced by burning fossil fuels.
RICHMOND, Calif., Sept.
A study published in this week's online issue of Nature Biotechnology, demonstrates a unique and highly sensitive method for detecting methylation-associated cancers.
When scientists first mapped out the human DNA in 2001, each attempt cost hundreds of millions of dollars and took an average of 250 people.
Molecules that selectively interfere with protein production can stop human cells from making the abnormal molecules that cause Huntingtonâ€™s disease, researchers at UT Southwestern Medical Center have found.
A team of UCSF researchers has for the first time used tiny molecules called microRNAs to help turn adult mouse cells back to their embryonic state.
- Company Receives Allowance of Patent Claims in the U.S. and in India - - InNexus Biotechnology CEO Highlighted in Nature Biotechnology - BRITISH COLUMBIA, Canada, March 6 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc.
A new "barcode chip" developed by researchers at the California Institute of Technology (Caltech) promises to revolutionize diagnostic medical testing. In less than 10 minutes, and using just a pinprick's worth of blood, the chip can measure the concentrations of dozens of proteins, including those that herald the presence of diseases like cancer and heart disease.